Analyst
MST Marquee
Andrew Goodsall
Healthcare Analyst
Request Access
About
Andrew Goodsall has specialised in Australian Healthcare equity research since 1999, and rated as the number one sector analyst in each of the major surveys since 2004. Prior to joining MST Marquee in 2017, he was with UBS and Citi. This followed pivotal roles in healthcare which included Chief of Staff to the Healthcare Minister in the reformist Kennett Government in Victoria in the 1990s. Andrew has serves on several healthcare boards, including the NSW Northern Sydney Local Health District (7 major public hospitals; $1.6b budget) and previously the Australian Institute of Health and Welfare. Andrews qualifications include; BA (Hons in Politics), MBA, Grad Dip Asian Studies.
Stock Coverage
Anteris Technology Ltd
AVR.AX
Cochlear Ltd
COH.AX
Healius Ltd
HLS.AX
CSL Ltd
CSL.AX
Sonic Healthcare Ltd
SHL.AX
Medibank Private Ltd
MPL.AX
Ramsay Health Care Ltd
RHC.AX
Neurotech International Ltd
NTI.AX
Australian Clinical Labs Limited
ACL.AX
Arovella Therapeutics Ltd
ALA.AX
Vitasora Health Ltd
VHL.AX
Request Access
Unlock comprehensive
analyst research and insights.
Already have an account? Log in

All material on this website has been prepared by MST Financial Services Pty Limited (ABN 54 617 475 180, AFSL 500 557) for general informational purposes only and is not a solicitation of any offer to buy or sell any financial instrument or to participate in any trading strategy. Unless otherwise stated, the material presented on this site is not a research report as defined under ASIC guidance. For wholesale clients only. This material is only prepared for wholesale clients pursuant to section 761G(7) of the Corporations Act (Commonwealth). Please also refer to MST's Privacy Policy, Terms of Use and Financial Services Guide.

Some of the products referred to on this website are issued by Equity Trustees Limited (ABN 46 004 031 298, AFSL 240975), the Responsible Entity of the funds. Equity Trustees is a subsidiary of EQT Holdings Limited (ABN 22 607 797 615), a company listed on the ASX (ASX: EQT). Before making any investment decision, you should carefully review the relevant disclosure documents, including the Product Disclosure Statement (PDS), Reference Guide (RG), and Target Market Determination (TMD), available from Equity Trustees. For MST Individually Managed Accounts (IMAs), please refer to the Information Memorandum. MST does not warrant the accuracy or completeness of the information provided and disclaims all liability for any errors or omissions, to the extent permitted by law. Past performance is not a reliable indicator of future performance.